Proteomics demonstration that normal breast epithelial cells can induce apoptosis of breast cancer cells through insulin-like growth factor-binding protein-3 and maspin

Molecular and Cellular Proteomics

Volumn 6, Issue 7, 2007, Pages 1239-1247

  Toillon, Robert Alain ^a   Lagadec, Chann ^a   Page, Adeline ^b   Chopin, Valérie ^a   Sautière, Pierre Eric ^b   Ricort, Jean Marc ^c   Lemoine, Jérôme ^d   Zhang, Ming ^e   Hondermarck, Hubert ^a   Bourhis, Xuefen Le ^a  

^a INSERM   (France)

^b UNIV LILLE   (France)

^c Ecole Normale Superieure de Cachan   (France)

^d UNIVERSITÉ LYON 1   (France)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MASPIN; RECOMBINANT PROTEIN; SOMATOMEDIN BINDING PROTEIN 3;

APOPTOSIS; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST EPITHELIUM; CANCER CELL; CANCER INHIBITION; CELL SECRETION; CELL STRAIN MCF 7; CONTROLLED STUDY; CULTURE MEDIUM; ELECTROSPRAY MASS SPECTROMETRY; EPITHELIUM CELL; HUMAN; HUMAN CELL; HYPOTHESIS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN SECRETION; PROTEOMICS; PURIFICATION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ULTRAFILTRATION; WESTERN BLOTTING;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; APOPTOSIS; BREAST NEOPLASMS; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; EPITHELIAL CELLS; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; MOLECULAR SEQUENCE DATA; PROTEOMICS; SERPINS; TANDEM MASS SPECTROMETRY;

EID: 34547130291     PISSN: 15359476     EISSN: None     Source Type: Journal    
DOI: 10.1074/mcp.M600477-MCP200     Document Type: Article

References (45)

1. Lacroix, M., Toillon, R. A., and Leclercq, G. (2004) Stable 'portrait' of breast tumors during progression: data from biology, pathology and genetics. Endocr. Relat. Cancer 11, 497-522
2. Ronnov-Jessen, L., Petersen, O. W., and Bissell, M. J. (1996) Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiol. Rev. 76, 69-125
3. Polyak, K. (2001) On the birth of breast cancer. Biochim. Biophys. Acta 1552, 1-13
4. Bissell, M. G., Radisky, D. C., Rizki, A., Weaver, V. M., and Petersen, O. W. (2002) The organizing principle: micro-environmental influences in the normal and malignant breast. Differentiation 70, 537-546
5. Allinen, M., Beroukhim, R., Cai, L., Brennan, C., Lahti-Domenici, J., Huang, H., Porter, D., Hu, M., Chin, L., Richardson, A., Schnitt, S., Sellers, W. R., and Polyak, K. (2004) Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 6, 17-32
6. Elenbaas, B., and Weinberg, R. A. (2001) Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. Exp. Cell Res. 264, 169-184
7. Sternlicht, M. D., Kedeshian, P., Shao, Z. M., Safarians, S., and Barsky, S. H. (1997) The human myoepithelial cell is a natural tumor suppressor. Clin. Cancer Res. 3, 1949-1958
8. Alpaugh, M. L., Lee, M. C., Nguyen, M,, Deato, M., Dishakjian, L., and Barsky, S. H. (2000) Myoepithelial-specific CD44 shedding contributes to the anti-invasive and antiangiogenic phenotype of myoepithelial cells. Exp. Cell Res. 261, 150-158
9. Nguyen, M., Lee, M. C., Wang, J. L., Tomlinson, J. S., Shao, Z. M., Alpaugh, M. L., and Barsky, S. H. (2000) The human myoepithelial cell displays a multi-faceted anti-angiogenic phenotype. Oncogene 19, 3449-3459
10. Zajchowski, D. A., Band, V., Trask, D. K., Kling, D., Connolly, J. L., and Sager, R. (1990) Suppression of tumor-forming ability and related traits in MCF-7 human breast cancer cells by fusion with immortal mammary epithelial cells. Proc. Natl. Acad. Sci. U. S. A. 87, 2314-2318
11. Dong-Le Bourhis, X., Berthois, Y., Millot, G., Degeorges, A., Sylvi, M., Martin, P. M., and Calvo, F. (1997) Effect of stromal and epithelial cells derived from normal and tumorous breast tissue on the proliferation of human breast cancer cell lines in co-culture. Int. J. Cancer 71, 42-48
12. Quarrie, L. H., Pitts, J. D., and Finbow, M. E. (1999) Interactions between normal mammary epithelial cells and mammary tumour cells in a model system. Cell Prolif. 32, 351-361
13. Spink, B. C., Cole, R. W., Katz, B. H., Gierthy, J. F., Bradley, L. M., and Spink, D. C. (2006) Inhibition of MCF-7 breast cancer cell proliferation by MCF-10A breast epithelial cells in coculture. Cell Biol. Int. 30, 227-238
14. Toillon, R. A., Chopin, V., Jouy, N., Fauquette, W., Boilly, B., and Le Bourhis, X. (2002) Normal breast epithelial cells induce p53-dependent apoptosis and p53-independent cell cycle arrest of breast cancer cells. Breast Cancer Res. Treat. 71, 269-280
15. Toillon, R. A., Descamps, S., Adriaenssens, E., Ricort, J. M., Bernard, D., Boilly, B., and Le Bourhis, X. (2002) Normal breast epithelial cells induce apoptosis of breast cancer cells via Fas signaling. Exp. Cell Res. 275, 31-43
16. Latha, K., Zhang, W., Celia, N., Shi, H. Y., and Zhang, M. (2005) Maspin mediates increased tumor cell apoptosis upon induction of the mitochondrial permeability transition. Mol. Cell. Biol. 25, 1737-1748
17. Vandermoere, F., El Yazidi-Belkoura, I., Slomianny, C., Demont, Y., Bidaux, G., Adriaenssens, E., Lemoine, J., and Hondermarck, H. (2006) The valosin-containing protein (VCP) is a target of Akt signaling required for cell survival. J. Biol. Chem. 281, 14307-14313
18. Lalou, C., Lassarre, C., and Binoux, M. (1996) A proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind IGFs inhibits the mitogenic effects of IGF-I and insulin. Endocrinology 137, 3206-3212
19. Jiang, N., Meng, Y., Zhang, S., Mensah-Osman, E., and Sheng, S. (2002) Maspin sensitizes breast carcinoma cells to induced apoptosis. Oncogene 21, 4089-4098
20. Liu, J., Yin, S., Reddy, N., Spencer, C., and Sheng, S. (2004) Bax mediates the apoptosis-sensitizing effect of maspin. Cancer Res. 64, 1703-1711
21. Kim, H. S., Ingermann, A. R., Tsubaki, J., Twigg, S. M., Walker, G. E., and Oh, Y. (2004) Insulin-like growth factor-binding protein 3 induces caspase-dependent apoptosis through a death receptor-mediated pathway in MCF-7 human breast cancer cells. Cancer Res. 64, 2229-2237
22. Lee, K. W., Ma, L., Yan, X, Liu, B., Zhang, X. K., and Cohen, P. (2005) Rapid apoptosis induction by IGFBP-3 involves an insulin-like growth factor-independent nucleomitochondrial translocation of RXRα/Nur77. J. Biol. Chem. 280, 16942-16948
23. Hondermarck, H. (2003) Breast cancer: when proteomics challenges biological complexity. Mol. Cell. Proteomics 2, 281-291
24. Hondermarck, H. (ed) (2004) Biomedical and Pharmaceutical Applications of Proteomics, Kluwer-Springer, Dordrecht, The Netherlands
25. Butt, A. J., Firth, S. M., King, M. A., and Baxter, R. C. (2000) Insulin-like growth factor-binding protein-3 modulates expression of Bax and Bcl-2 and potentiates p53-independent radiation-induced apoptosis in human breast cancer cells. J. Biol. Chem. 275, 39174-39181
26. Bernard, L., Babajko, S., Binoux, N., and Ricort, J. M. (2002) The amino-terminal region of insulin-like growth factor binding protein-3, (1-95) IGFBP-3, induces apoptosis of MCF-7 breast carcinoma cells. Biochem. Biophys. Res. Commun. 293, 55-60
27. Miyamoto, S., Yano, K., Sugimoto, S., Ishii, G., Hasebe, T., Endoh, Y., Kodama, K., Goya, M., Chiba, T., and Ochiai, A. (2004) Matrix metallo-proteinase-7 facilitates insulin-like growth factor bioavailability through its proteinase activity on insulin-like growth factor binding protein 3. Cancer Res. 64, 665-671
28. Mishra, S., and Murphy, L. J. (2003) Phosphorylation of insulin-like growth factor (IGF) binding protein-3 by breast cancer cell membranes enhances IGF-I binding. Endocrinology 144, 4042-4050
29. Schedlich, L. J., Young, T. F., Firth, S. M., and Baxter, R. C. (1998) Insulin-like growth factor-binding protein (IGFBP)-3 and IGFBP-5 share a common nuclear transport pathway in T47D human breast carcinoma cells. J. Biol. Chem. 273, 18347-18352
30. Schedlich, L. J., Nilsen, T., John, A. P., Jans, D. A., and Baxter, R. C. (2003) Phosphorylation of insulin-like growth factor binding protein-3 by deoxyribonucleic acid-dependent protein kinase reduces ligand binding and enhances nuclear accumulation. Endocrinology 144, 1984-1994
31. Firth, S. M., and Baxter, R. C. (1999) Characterisation of glycosylation variants of insulin-like growth factor binding protein-3. J. Endocrinol. 160, 379-387
32. Shi, H. Y., Zhang, W., Liang, R., Kittrell, F., Templeton, N. S., Medina, D., and Zhang, M. (2003) Modeling human breast cancer metastasis in mice: maspin as a paradigm. Histol. Histopathol. 18, 201-206
33. Bailey, C. M., Khalkhali-Ellis, Z., Seftor, E., and Hendrix, M. J. C. (2006) Biological functions of maspin. J. Cell. Physiol. 209, 617-624
34. Sheng, S. (2006) A role of novel serpin maspin in tumor progression: the divergence revealed through efforts to converge. J. Cell. Physiol. 209, 631-635
35. Zhang, W., Shi, H. Y., and Zhang, M. (2005) Maspin overexpression modulates tumor cell apoptosis through the regulation of Bcl-2 family proteins. BMC Cancer 5, 50
36. Biliran, H. Jr., and Sheng, S. (2001) Pleiotropic inhibition of pericellular urokinase-type plasminogen activator system by endogenous tumor suppressive maspin. Cancer Res. 61, 8676-8682
37. Amir, S., Margaryan, N. V., Odero-Marah, V., Khalkhali-Ellis, Z., and Hendrix, M. J. C. (2005) Maspin regulates hypoxia-mediated stimulation of uPA/uPAR complex in invasive breast cancer cells. Cancer Biol. Ther. 4, 400-406
38. Yin, S., Lockett, J., Meng, Y., Biliran, H. J., Blouse, G. E., Li, X., Reddy, N., Zhao, Z., Lin, X., Anagli, J., Cher, M. L., and Sheng, S. (2006) Maspin retards cell detachment via a novel interaction with the urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor system. Cancer Res. 66, 4173-4181
39. Ossowski, L., and Aguirre-Ghiso, J. A. (2000) Urokinase receptor and integrin partnership: coordination of signaling for cell adhesion, migration and growth. Curr. Opin. Cell Biol. 12, 613-620
40. Odero-Marah, V. A., Khalkhali-Ellis, Z., Chunthapong, J., Amir, S., Seftor, R. E., Seftor, E. A., and Hendrix, M. J. C. (2003) Maspin regulates different signaling pathways for motility and adhesion in aggressive breast cancer cells. Cancer Biol. Ther. 2, 398-403
41. Toillon, R. A., Adriaenssens, E., Wouters, D., Lottin, S., Boilly, B., Hondermarck, H., and Le Bourhis, X. (2000) Normal breast epithelial cells induce apoptosis of MCF-7 breast cancer cells through a p53-mediated pathway. Mol. Cell. Biol. Res. Commun. 3, 338-344
42. Hanafusa, T., Shinji, T., Shiraha, H., Nouso, K., Iwasaki, Y., Yumoto, E., Ono, T., and Koide, N. (2005) Functional promoter upstream p53 regulatory sequence of IGFBP3 that is silenced by tumor specific methylation. BMC Cancer 5, 9
43. Futscher, B. W., Oshiro, M. M., Wozniak, R. J., Holtan, N., Hanigan, C. L., Duan, H., and Domann, F. E. (2002) Role for DNA methylation in the control of cell type specific maspin expression. Nat. Genet. 31, 175-179
44. Lockett, J., Yin, S., Li, X., Meng, Y., and Shang, S. (2006) Tumor suppressive maspin and epithelial homeostasis. J. Cell. Biochem. 97, 651-660
45. Martin, J. L., Weenink, S. M., and Baxter, R. C. (2003) Insulin-like growth factor-binding protein-3 potentiates epidermal growth factor action in MCF-10A mammary epitheliall cells. Involvement of p44/42 and p38 mitogen-activated protein kinases. J. Biol. Chem. 278, 2969-2976